Medical-device makers should assess the potential reimbursement rates of products at the early stage of the development process, writes John Avellanet, Cerulean Associates' managing director. Evaluating the reimbursement implications early on could help companies to determine the profitability of a product before it reaches the market, Avellanet said.

Related Summaries